Product
ZM-01-H
Aliases
rAAV-hRS1
1 clinical trial
1 indication
Indication
X-linked retinoschisisClinical trial
Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-01 in 3-18 Year-old Male Subjects With X-linked RetinoschisisStatus: Recruiting, Estimated PCD: 2023-10-31